08-06 Biosynex hit by cyberattack, operational activity remains intact Zonebourse
06-11 Triple update for Biosynex Zonebourse
06-10 An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million. CI
05-25 Biosynex announces the divestment of its molecular biology business Zonebourse
05-24 An undisclosed buyer signed a binding offer to acquire Entire internal molecular biology business from Biosynex SA for ?4 million. CI
05-07 Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
05-06 Biosynex SA Auditor Raises 'Going Concern' Doubt CI
04-21 Biosynex postpones publication of annual accounts Zonebourse
03-24 Observation period extended for Biosynex Zonebourse
02-06 A Biosynex Subsidiary to Receive $1.8 Million Grant Zonebourse
01-22 Biosynex Announces FDA Review Request for a Product Zonebourse
01-16 Biosynex: To Watch Today Zonebourse
01-15 Biosynex Targets Gradual Business Restart in 2026 Zonebourse
12-31 Biosynex: To Watch Today Zonebourse
12-30 Biosynex: Brigitte Geny Resigns from Her Position as Independent Director Zonebourse
25-10-30 Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-04-29 Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-01-21 Biosynex SA announced that it expects to receive ?7.987161 million in funding CI
25-01-14 Biosynex: 9% sales growth by 2024 Zonebourse
24-11-03 Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2024 CI
24-10-23 BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY EQ
24-07-19 Biosynex: return to growth, share price rises Zonebourse
24-05-28 Biosynex: obtains CE markings under the new IVDR regulations Zonebourse
24-05-13 Biosynex: Oren Bitton appointed Chief Operating Officer Zonebourse
24-04-30 Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
No results match your criteria